Oncimmune Holdings plc announced that Dr Adam M Hill will be stepping down as Chief Executive Officer, and as a director of the Company. Adam will support Oncimmune in the short term by providing continuity in some of the Company's ongoing commercial efforts and supporting a transition of his responsibilities and relationships to the new CEO and other colleagues as appropriate. Pending the appointment of a permanent successor, the Board has appointed Ron Kirschner, the Company's General Counsel and Company Secretary, as acting CEO, and a director of the Company.